World's Best Scientists 2026 revealed!
Mehala Subramaniapillai

Mehala Subramaniapillai

Award Badge
Rising Stars
2025

D-Index & Metrics

Rising Stars

D-Index
37
Citations
6921
World Ranking
753
National Ranking
18

Psychology

D-Index
42
Citations
8585
World Ranking
7487
National Ranking
507

Mehala Subramaniapillai publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Mehala Subramaniapillai sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 124 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Mehala Subramaniapillai D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Mehala Subramaniapillai sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 42 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Rising Stars Award

Overview

Mehala Subramaniapillai is affiliated with the University of Toronto in Canada and has a substantial publication record in the fields of Medicine, Psychology, and Neuroscience. Their research spans several subfields, including Biological Psychiatry, Pharmacology, Experimental and Cognitive Psychology, Psychiatry and Mental Health, and Neurology.

Their main topics of study involve diverse subjects, prominently featuring:

  • Tryptophan and brain disorders
  • Treatment of Major Depression
  • Long-Term Effects of COVID-19
  • Mental Health Research Topics
  • COVID-19 and Mental Health
  • Bipolar Disorder and Treatment
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Among their recent notable papers are:

  • Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis (2021), published in Brain Behavior and Immunity
  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation (2021), published in American Journal of Psychiatry
  • Onset and frequency of depression in post-COVID-19 syndrome: A systematic review (2021), published in Journal of Psychiatric Research
  • Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries (2021), published in Journal of Affective Disorders
  • Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death (2021), published in JAMA Psychiatry

They frequently publish in the following venues:

  • Journal of Affective Disorders
  • Psychiatry Research
  • Journal of Psychiatric Research
  • CNS Spectrums
  • Brain Behavior and Immunity

Subramaniapillai has collaborated extensively with a number of researchers, including:

  • Roger S. McIntyre
  • Joshua D. Rosenblat
  • Rodrigo B. Mansur
  • Yena Lee
  • Roger Ho

Best Publications

  • Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis

    Unknown

  • Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

    Roger S McIntyre;Roger S McIntyre;Joshua D Rosenblat;Joshua D Rosenblat;Charles B Nemeroff;Gerard Sanacora

  • Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review

    Yena Lee;Renee-Marie Ragguett;Rodrigo B. Mansur;Justin J. Boutilier

  • Onset and frequency of depression in post-COVID-19 syndrome: A systematic review.

    Olivier Renaud-Charest;Leanna M.W. Lui;Sherry Eskander;Felicia Ceban

  • Cognitive impairment in major depressive disorder.

    Zihang Pan;Caroline Park;Elisa Brietzke;Hannah Zuckerman

  • Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries.

    Yena Lee;Leanna M.W. Lui;David Chen-Li;Yuhua Liao

  • Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis.

    Felicia Ceban;Felicia Ceban;Danica Nogo;Isidro P. Carvalho;Yena Lee

  • Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments.

    Elisa Brietzke;Elisa Brietzke;Rodrigo B. Mansur;Mehala Subramaniapillai;Vicent Balanzá-Martínez

  • Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial.

    Roger S McIntyre;Mehala Subramaniapillai;Yena Lee;Yena Lee;Zihang Pan;Zihang Pan

  • The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis.

    Roger S. McIntyre;Isabelle P. Carvalho;Leanna M.W. Lui;Amna Majeed

  • The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.

    Roger S. McIntyre;Roger S. McIntyre;Michael W. Best;Christopher R. Bowie;Christopher R. Bowie;Nicole E. Carmona

  • Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study.

    Rodrigo B. Mansur;Rodrigo B. Mansur;Juhie Ahmed;Danielle S. Cha;Hanna O. Woldeyohannes

  • The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder

    Bing Cao;Caroline Park;Mehala Subramaniapillai;Yena Lee;Yena Lee

  • Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder

    Carola Rong;Caroline Park;Joshua D. Rosenblat;Mehala Subramaniapillai

  • Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression

    Julia A. Hamer;Daniela Testani;Rodrigo B. Mansur;Yena Lee

  • Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review.

    Yena Lee;Joshua D. Rosenblat;JungGoo Lee;Nicole E. Carmona

  • Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.

    Susan Ling;Susan Ling;Felicia Ceban;Leanna M W Lui;Yena Lee

  • Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research

    Unknown

  • The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence.

    Roger S McIntyre;Roger S McIntyre;Nelson B Rodrigues;Yena Lee;Orly Lipsitz

  • The Mental Health Effects of COVID-19 on Health Care Providers in China.

    Kangguang Lin;Bing Xiang Yang;Dan Luo;Qian Liu

  • Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents

    Carola Rong;Nicole E Carmona;Yena L Lee;Renee-Marie Ragguett

  • Leptin and adiponectin levels in major depressive disorder: A systematic review and meta-analysis

    Bing Cao;Yan Chen;Elisa Brietzke;Danielle Cha

  • The effect of caloric restriction on working memory in healthy non-obese adults.

    Emilie Leclerc;Alisson Paulino Trevizol;Ruth B Grigolon;Mehala Subramaniapillai

Frequent Co-Authors

Roger S. McIntyre
Roger S. McIntyre University of Toronto
Rodrigo B. Mansur
Rodrigo B. Mansur University Health Network
Roger C.M. Ho
Roger C.M. Ho Hong Kong University of Science and Technology
Elisa Brietzke
Elisa Brietzke Queen's University
Guy Faulkner
Guy Faulkner University of British Columbia
Trisha Suppes
Trisha Suppes Stanford University
Maj Vinberg
Maj Vinberg University of Copenhagen
Natalie L. Rasgon
Natalie L. Rasgon Stanford University
Christopher R. Bowie
Christopher R. Bowie Queen's University
Gary Remington
Gary Remington Centre for Addiction and Mental Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying psychology can open diverse doors in both academic and applied settings. For those seeking the highest level of expertise, many universities now offer flexible phd programs for psychology that prepare graduates for advanced research, teaching, and clinical roles.

Specializations are also widely available. For instance, students interested in the intersection of law and mental health might explore accredited online phd forensic psychology degrees. These programs are ideal for those aiming to consult within legal systems or criminal investigations.

Another in-demand path is school psychology. Candidates can choose from nasp approved school psychology programs online, which allow you to earn credentials recognized for school-based positions nationwide.

If you want a faster route to advancement or licensure, consider the best one-year online master’s in psychology degree programs. These intensive offerings can help you develop practical skills or begin work toward a doctoral track in much less time.

Best Scientists Citing Mehala Subramaniapillai

Trending Scientists

Recently Published Articles